ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1283

Atherogenic Index of Plasma Identifies Patients with Rheumatoid Arthritis and Increased Carotid Intima-Media Thickness

Dionicio A. Galarza-Delgado1, Iris Colunga1, José Ramón Azpiri-López1, Valeria Gonzalez-Gonzalez2, Victor Beltran3, Angel Arias Peralta4, Jesus Alberto Cardenas-De la Garza5 and Rosa Arvizu-Rivera6, 1Hospital Universitario UANL, Monterrey, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Rheumatology Service Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 4Medicine Faculty, Universidad Autonoma De Nuevo Leon, Monterrey, Mexico, 5Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico, 6Hospital Universitario "Dr. José Eleuterio Gonzalez", Escobedo, Mexico

Meeting: ACR Convergence 2023

Keywords: Atherosclerosis, Cardiovascular, Carotid Artery Disease, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The atherogenic index of plasma (AIP) is a novel marker to identify cardiovascular disease. Recently, AIP was reported to be related to long-term cardiovascular disease risk in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). We aimed to evaluate if RA-patients with high AIP present a higher prevalence of carotid plaque than patients with RA and low AIP.

Methods: A cross-sectional and comparative study including RA-patients aged 40 to 75 who fulfilled the ACR/EULAR 2010 classification criteria for RA. Patients with previous cardiovascular disease were excluded. Carotid ultrasound was performed on all study participants. The presence of carotid plaque (CP) was defined as diffuse carotid intima-media thickness (cIMT) ≥1.2 mm or focal thickness ≥0.5 mm. Subclinical atherosclerosis was defined as the presence of CP or an increased cIMT (≥0.8mm). Cardiovascular disease risk was evaluated using 6 algorithms: ACC/AHA 2013, FRS-Lipids, FRS-BMI, RRS, QRISK3, and SCORE2. AIP was defined by log (TG/HDL-C) mg/dL, and levels ≥0.21 were considered as high AIP. Patients were divided into two groups according to AIP levels. The distribution between groups was assessed with the Kolmogorov-Smirnov test. Comparisons with Chi-square or Fisher’s exact test and Student’s t-test or Mann Whitney’s U-test, accordingly. A value of p≤0.05 was considered statistically significant.

Results: A total of 144 patients with RA were included, most of which were women (n=133, 94%). There was no difference between sex, traditional cardiovascular risk factors, disease activity, or disease duration between patients with high AIP and those RA-patients with low AIP (Table 1). The prevalence of CP (37.5% vs 25.0%, p=0.106) and overall subclinical atherosclerosis (58.3% vs 62.5%, p=0.609) was similar between groups (Table 1). However, the prevalence of increased cIMT was higher in RA-patients with high AIP (29.2% vs 54.2%, p=0.002). Cardiovascular risk was increased in patients with high AIP using FRS-Lipids Score (7.6 vs 9.6, p=0.037) and RRS (1.5 vs 1.5, p=0.009) (Table 2).

Conclusion: The prevalence of increased cIMT was higher in RA-patients and had a high atherogenic index of plasma (AIP). AIP could be a helpful marker for the early identification of patients with increased cIMT.

Supporting image 1

Table 1. Demographic characteristics.

Supporting image 2

Table 2. Cardiovascular risk algorithms.


Disclosures: D. Galarza-Delgado: None; I. Colunga: None; J. Azpiri-López: None; V. Gonzalez-Gonzalez: None; V. Beltran: None; A. Arias Peralta: None; J. Cardenas-De la Garza: None; R. Arvizu-Rivera: None.

To cite this abstract in AMA style:

Galarza-Delgado D, Colunga I, Azpiri-López J, Gonzalez-Gonzalez V, Beltran V, Arias Peralta A, Cardenas-De la Garza J, Arvizu-Rivera R. Atherogenic Index of Plasma Identifies Patients with Rheumatoid Arthritis and Increased Carotid Intima-Media Thickness [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/atherogenic-index-of-plasma-identifies-patients-with-rheumatoid-arthritis-and-increased-carotid-intima-media-thickness/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/atherogenic-index-of-plasma-identifies-patients-with-rheumatoid-arthritis-and-increased-carotid-intima-media-thickness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology